Future Therapies for Multiple Sclerosis.

Future immunotherapy for immune-mediated neurologic diseases is in a state of rapid development. The current therapeutic arsenal consists of a mixture of older and new agents whose uses are actively being redefined. Our current understanding of mechanisms of action of established medications and developing approaches will be discussed in relation to disease pathogenesis models. Also, we will present a framework for incorporating current and future therapies into rational treatment strategies and will be addressed together with a review of relevant clinical studies. Mechanisms of immunotherapy and clinical strategies will be discussed in the context of multiple sclerosis (MS). [ABSTRACT FROM AUTHOR]